White-label Claude for Vet Clinics

Diving deeper into

Modern Animal

Company Report
Offering Claude as white-label software could significantly increase the company's addressable market.
Analyzed 8 sources

The bigger opportunity is not opening more clinics, it is turning Modern Animal’s internal operating system into software that other clinics pay for every month. Claude already sits at the center of how Modern Animal books visits, shares records across clinics, and cuts doctor admin time with AI documentation. Selling that same workflow to outside hospitals would let Modern Animal monetize the veterinary labor shortage without having to staff and build every location itself.

  • Modern Animal’s current business is still mostly service revenue. Memberships are about 12% of revenue, while 88% comes from clinic services, diagnostics, procedures, and pharmacy. Software would add a much more recurring and higher gross margin layer on top of a capital intensive clinic base.
  • The market on paper is much larger than Modern Animal’s owned footprint. The company runs 27 clinics today, while AAHA materials point to roughly 25,000 veterinary hospital locations nationwide, and Grand View projects the U.S. veterinary software market at $1.07B by 2030.
  • The closest analog is AI medical scribe software in human healthcare. Companies like Suki, Abridge, Ambience, and Freed have shown that automating notes can become a real software category, but the hard part is deep workflow integration, not just transcription. That same lesson applies in vet clinics.

If Claude moves outside Modern Animal’s walls, the likely path is from AI note writing into full practice infrastructure, including intake, scheduling, records, and follow up. That would shift Modern Animal from a premium clinic chain into a category defining veterinary software company, with clinic operations serving as the proving ground for products sold across the rest of the market.